Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040568
Filing Date
2023-08-09
Accepted
2023-08-09 16:08:20
Documents
84
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amam-20230630.htm   iXBRL 10-Q 4481261
2 EX-3.2 amam-ex3_2.htm EX-3.2 16727
3 EX-4.3 amam-ex4_3.htm EX-4.3 194480
4 EX-4.4 amam-ex4_4.htm EX-4.4 23228
5 EX-31.1 amam-ex31_1.htm EX-31.1 20959
6 EX-31.2 amam-ex31_2.htm EX-31.2 20920
7 EX-32.1 amam-ex32_1.htm EX-32.1 11779
8 EX-32.2 amam-ex32_2.htm EX-32.2 11459
9 GRAPHIC img46787537_0.jpg GRAPHIC 8386
  Complete submission text file 0000950170-23-040568.txt   16009734

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amam-20230630_lab.xml EX-101.LAB 683472
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amam-20230630_pre.xml EX-101.PRE 535287
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amam-20230630_def.xml EX-101.DEF 398978
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amam-20230630_cal.xml EX-101.CAL 67447
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amam-20230630.xsd EX-101.SCH 89276
78 EXTRACTED XBRL INSTANCE DOCUMENT amam-20230630_htm.xml XML 3439360
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

EIN.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40505 | Film No.: 231155171
SIC: 2836 Biological Products, (No Diagnostic Substances)